Contact usLogin

Top Brand

40%
MoleculeSalt Composition

Metformin 500mg + Voglibose 0.3mg

Our Recommendation

Vogliboz M 500/0.3mg SR Tablet 10s

Vogliboz M 500/0.3mg SR Tablet 10s

Knoll Pharmaceuticals Ltd.
Strip of 10 tablets

3,731+ trust this

who

WHO GMP Certified

3,731+ trust this

who

WHO GMP Certified

Doctor verified video thumbnail
All Our Medicines are
who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

Delivery by

Used In

Treatment of Type 2 diabetes mellitus

Customers also bought

More About Vogliboz M

Benefits
Side Effects
How to use
How it works
What if I forget to take it?
Manufacturer Address

Benefits

Treatment of Type 2 diabetes mellitusTreatment of Type 2 diabetes mellitus

In Treatment of Type 2 diabetes mellitus Vogliboz M 500 mg/0.3 mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Vogliboz M 500 mg/0.3 mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.In Treatment of Type 2 diabetes mellitus Vogliboz M 500 mg/0.3 mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Vogliboz M 500 mg/0.3 mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.

Side Effects

The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.

How to use

Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Vogliboz M 500 mg/0.3 mg Tablet is to be taken with food.Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Vogliboz M 500 mg/0.3 mg Tablet is to be taken with food.

How it works

Vogliboz M 500 mg/0.3 mg Tablet is a combination of two antidiabetic medicines: Metformin and voglibose. Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin. Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.Vogliboz M 500 mg/0.3 mg Tablet is a combination of two antidiabetic medicines: Metformin and voglibose. Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin. Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.

Alcohol

Unsafe: Avoid consuming alcohol with Vogliboz M 500 mg/0.3mg Tablet as it is deemed unsafe.Unsafe: Avoid consuming alcohol with Vogliboz M 500 mg/0.3mg Tablet as it is deemed unsafe.

Pregnancy

Seek medical advice from your doctor: Vogliboz M 500 mg/0.3 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.Seek medical advice from your doctor: Vogliboz M 500 mg/0.3 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.

Breast feeding

Seek medical advice from your doctor: Vogliboz M 500 mg/0.3 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Seek medical advice from your doctor: Vogliboz M 500 mg/0.3 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

SAFE - Vogliboz M 500 mg/0.3 mg Tablet does not usually affect your ability to drive. However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.SAFE - Vogliboz M 500 mg/0.3 mg Tablet does not usually affect your ability to drive. However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.

Kidney

Caution Advised: Vogliboz M 500 mg/0.3 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vogliboz M 500 mg/0.3 mg Tablet may be needed. Doctor consultation is advised. Use of Vogliboz M 500 mg/0.3 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.Caution Advised: Vogliboz M 500 mg/0.3 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vogliboz M 500 mg/0.3 mg Tablet may be needed. Doctor consultation is advised. Use of Vogliboz M 500 mg/0.3 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Liver

Seek medical advice from your doctor: There is limited information available on the use of Vogliboz M 500 mg/0.3 mg Tablet in patients with liver disease. Doctor consultation is advised.Seek medical advice from your doctor: There is limited information available on the use of Vogliboz M 500 mg/0.3 mg Tablet in patients with liver disease. Doctor consultation is advised.

What if I forget to take it?

If a dose of Vogliboz M 500 mg/0.3mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.If a dose of Vogliboz M 500 mg/0.3mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.

Manufacturer Address

M-17, Pharma Tower, Basement & Ground Floor, Badli Industrial Area, New Delhi 110 042

Checkout Editorial Policy

References

  • CiplaMed. Voglibose + Metformin hydrochloride (08 Apr. 2019)

  • Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)

  • Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)

  • Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)

  • Metformin hydrochloride and Voglibose (Tablets) (21 Oct. 2021)

  • Voglibose and Metformin Hydrochloride Tablets (28th Sept. 2023)

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.